Inge Reinieren-Beeren

Abstract 6921: Phosphonate-antibody-drug conjugates, a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing

Mary J. van Helden, Genny Filliciotto, Wendela A. Kappers, Diels van den Dobbelsteen et autres

954 Phosphonate-antibody-drug conjugates: a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing

Mary J. van Helden, Genny Filiciotto, Wendela A. Kappers, Panagiota I. Spantidea et autres

nl (code pays fourni par la source)

Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists

Maarten van der Linden, Sangeeta Kumari, S. van Dalen, Annemarie Kip et autres

cn, us (code pays fourni par la source)

Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases

Maarten van der Linden, Sangeeta Kumari, Daphne Montizaan, S. van Dalen et autres

us, gb, nl, de (code pays fourni par la source)

Abstract 2934: BYON4228, an antagonistic SIRPα mAb with a unique and favorable preclinical profile compared to three comparator SIRPα mAbs

Mary van Helden, Seline A. Zwarthoff, Roel Arends, Inge Reinieren-Beeren et autres

nl (code pays fourni par la source)

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

Mary J. van Helden, Seline A. Zwarthoff, Roel J. Arends, Inge Reinieren-Beeren et autres

nl (code pays fourni par la source)

495 BYON4228, a pan-allelic SIRPα blocking antibody with a favorable pre-clinical safety profile, enhances anti-tumor immunity in vitro and in vivo

Mary van Helden, Roel Arends, Seline A. Zwarthoff, Monique van der Vleuten et autres

nl (code pays fourni par la source)

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint

Erik Voets, Marc Paradé, D. Lutje Hulsik, Sanne Spijkers et autres

us (code pays fourni par la source)

Abstract 1203: Preclinical development of ADU-1805, a highly selective pan-allele anti-SIRPα antibody that blocks the SIRPα-CD47 innate immune checkpoint

Erik Voets, Joost H. C. M. Kreijtz, Paul Vink, D. Lutje Hulsik et autres

us (code pays fourni par la source)

Abstract 1203: Preclinical development of ADU-1805, a highly selective pan-allele anti-SIRPα antibody that blocks the SIRPα-CD47 innate immune checkpoint

Erik Voets, Joost H. C. M. Kreijtz, Paul Vink, D. Lutje Hulsik et autres

us (code pays fourni par la source)

N-glycan mediated adhesion strengthening during pathogen-receptor binding revealed by cell-cell force spectroscopy

Joost te Riet, Ben Joosten, Inge Reinieren-Beeren, Carl G. Figdor et autres

nl, us (code pays fourni par la source)

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

Sonja I. Buschow, Matteo Ramazzotti, Inge Reinieren-Beeren, Lucie Heinzerling et autres

nl, it, de, dk, at, gb, ca (code pays fourni par la source)